Eckert & Ziegler BEBIG, Mick Radio-Nuclear Instruments, WOLF-Medizintechnik (WOmed)


Wir halten Sie auf dem Laufenden! Wenn Sie Fragen zu unseren Pressemitteilungen haben, können Sie uns gerne über das Kontaktformular der Website kontaktieren. Bleiben Sie über die neuesten Nachrichten unseres Unternehmens auf dem Laufenden:

IBt - International Brachytherapy s.a.: Expansion in Russia

Embargo until 17h40 (Brussels time) October 2nd , 2008

Expansion in Russia
Development of a Joint Venture

Seneffe - 2 October 2008

IBt - (Reuters: IBTH.BR - Bloomberg: IBTB BB)

IBt s.a. has entered into exclusive negotiations with the "Russian Corporation for Nanotechnologies" (RNT) and "000 Bebig", two Russian companies, in order to set-up a joint venture in the Russian Federation. The aim of the joint venture is to develop a high tech company focused on the production and the development of radioactive microsources, microspheres and accessories used for the treatment of cancer by brachytherapy.

Under the terms of proposed agreement, the parties would create a joint venture to be based in Moscow. IBt would be a co-investor and make a contribution in kind into the capital of the joint venture by providing access to its technology, know-how and its intellectual property portfolio. In return, IBt would receive a stake in the equity of the company to be created. The total value of the joint venture would exceed 7 mm EUR.

About the two Russian partners:

(1) "Russian Corporation for Nanotechnologies" will be the main partner in the joint venture, providing funding and some equipments,
(2) "000 Bebig", Founded in July 2004, the company has, together with its strategic partner: "Zavod Medradiopreparat", succeeded in developing the Russian market significantly. It is today the only company distributing radioactive microsources in the entire Russian Federation.

IBt BEBIG Group designs, produces and markets worldwide a complete range of radiotherapy implants used in permanent brachytherapy. Since IBt acquired the company BEBIG GmbH in February 2008, the group is today the leader in its segment of activities and includes subsidiaries based in Germany, France, UK, Ireland, Spain, and Italy as well as a large number of distributors spread throughout the world.

François Blondel, CEO, Managing Director
Laurence Goemaere
Tel: +32 (0)064.520811
Site Internet: